• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

基于免疫状态的III期乳腺癌多药化疗个体化

[Individualization of polychemotherapy for stage III breast cancer based on immunologic status].

作者信息

Sabala P I

出版信息

Vopr Onkol. 1984;30(11):44-8.

PMID:6516259
Abstract

Immunologic response was studied in 91 cases of stage III breast cancer who received a CFMVP polychemotherapy. 23 patients were given decaris for immunostimulation. All cases showed a significant decrease in cellular immunity. CFMVP-treated patients showing a decrease of 30% and more should receive 300 mg of decaris twice a week for 3 weeks.

摘要

对91例接受CFMVP联合化疗的III期乳腺癌患者的免疫反应进行了研究。23例患者给予迪卡菌进行免疫刺激。所有病例的细胞免疫均显著下降。CFMVP治疗后细胞免疫下降30%及以上的患者，应每周两次服用300毫克迪卡菌，共3周。

相似文献

1
[Individualization of polychemotherapy for stage III breast cancer based on immunologic status].基于免疫状态的III期乳腺癌多药化疗个体化
Vopr Onkol. 1984;30(11):44-8.
2
[Immunomodulating effects of indomethacin in breast cancer].[吲哚美辛对乳腺癌的免疫调节作用]
Sov Med. 1987(8):27-30.
3
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.一项随机试验，比较环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）与交替使用CMF、表柔比星和长春新碱作为可手术乳腺癌的一线化疗方案。
Cancer. 2002 Jul 15;95(2):228-35. doi: 10.1002/cncr.10678.
4
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松辅助化疗与单药左旋苯丙氨酸氮芥治疗可手术乳腺癌且腋窝淋巴结阳性患者的比较：西南肿瘤协作组20年研究结果
Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982.
5
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.贫血是接受辅助性环磷酰胺/甲氨蝶呤/5-氟尿嘧啶化疗的绝经前原发性乳腺癌患者局部无复发生存的一个重要预后因素。
Clin Cancer Res. 2008 Apr 1;14(7):2082-7. doi: 10.1158/1078-0432.CCR-07-2068.
6
Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
Cancer Treat Rep. 1980 Jan;64(1):65-72.
7
[Treatment of metastasized breast cancer].[转移性乳腺癌的治疗]
Z Erkr Atmungsorgane. 1986;166(1):112-5.
8
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.格拉司琼与泼尼松龙加甲氧氯普胺在多个周期的中度致吐性化疗中作为止吐预防用药的比较。
Br J Cancer. 1999 May;80(3-4):412-8. doi: 10.1038/sj.bjc.6690372.
9
Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.早期乳腺癌的多药化疗：国际辅助性乳腺癌化疗随机试验的结果
J Natl Cancer Inst. 2007 Apr 4;99(7):506-15. doi: 10.1093/jnci/djk108.
10
[Sequential combination chemotherapy in metastatic cancer of the breast].[转移性乳腺癌的序贯联合化疗]
Medicina (B Aires). 1984;44(1):15-22.